Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Ping-Ching Hsu

Concepts (534)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Helicobacter pylori
11
2014
65
2.030
Why?
Helicobacter Infections
9
2014
63
1.940
Why?
Carcinoma, Non-Small-Cell Lung
6
2024
166
1.250
Why?
Smoking
5
2016
516
1.230
Why?
Hepatitis B, Chronic
7
2014
17
1.220
Why?
Tumor Necrosis Factor-alpha
6
2014
392
1.150
Why?
Hepatitis B virus
5
2014
24
1.040
Why?
Menthol
2
2016
17
1.000
Why?
Lung Neoplasms
7
2024
624
0.980
Why?
Metabolome
2
2016
103
0.840
Why?
Nicotine
2
2016
175
0.830
Why?
Carcinoma, Hepatocellular
8
2014
199
0.790
Why?
Liver Neoplasms
9
2014
332
0.790
Why?
Middle Aged
48
2024
13028
0.750
Why?
Spermatozoa
3
2007
25
0.710
Why?
Apoptosis
6
2014
1117
0.690
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2024
1020
0.650
Why?
Lymphocyte Activation
4
2024
160
0.650
Why?
Peptic Ulcer
3
2010
14
0.640
Why?
Aged
37
2024
10142
0.620
Why?
Induction Chemotherapy
1
2019
64
0.600
Why?
TNF-Related Apoptosis-Inducing Ligand
5
2012
20
0.600
Why?
Male
58
2024
26652
0.600
Why?
Membrane Glycoproteins
3
2005
238
0.600
Why?
Metabolomics
2
2016
151
0.580
Why?
Cisplatin
3
2019
284
0.570
Why?
Female
52
2024
28055
0.550
Why?
Proton Pump Inhibitors
2
2010
86
0.550
Why?
Apoptosis Regulatory Proteins
5
2010
86
0.540
Why?
Genetic Predisposition to Disease
4
2024
528
0.530
Why?
Hepatitis B Core Antigens
2
2014
7
0.520
Why?
Polychlorinated Biphenyls
3
2007
35
0.520
Why?
Glucuronates
1
2016
22
0.510
Why?
Humans
70
2024
52114
0.500
Why?
Testis
2
2007
72
0.490
Why?
Adult
35
2024
14095
0.490
Why?
Up-Regulation
7
2014
459
0.490
Why?
Gastritis
2
2007
33
0.480
Why?
Gastrointestinal Hemorrhage
7
2014
91
0.470
Why?
Programmed Cell Death 1 Receptor
2
2012
39
0.460
Why?
Endoscopy, Digestive System
2
2012
52
0.430
Why?
Anti-Bacterial Agents
6
2014
796
0.420
Why?
Aged, 80 and over
14
2024
3382
0.410
Why?
Disease Models, Animal
3
2014
1467
0.410
Why?
Immunity, Innate
1
2014
112
0.410
Why?
Lymphoma, B-Cell, Marginal Zone
2
2010
24
0.400
Why?
Esophageal and Gastric Varices
6
2012
17
0.400
Why?
Cholecystolithiasis
1
2012
1
0.390
Why?
Bile Duct Diseases
1
2012
11
0.390
Why?
Choledocholithiasis
1
2012
13
0.390
Why?
Taiwan
7
2014
28
0.380
Why?
Antigens, Bacterial
2
2010
52
0.380
Why?
Duodenal Ulcer
3
2009
10
0.370
Why?
Tobacco Products
2
2015
127
0.370
Why?
CD8-Positive T-Lymphocytes
1
2012
128
0.350
Why?
Galectin 3
1
2011
14
0.350
Why?
Lymphocyte Specific Protein Tyrosine Kinase p56(lck)
1
2010
3
0.350
Why?
Membrane Microdomains
1
2010
12
0.340
Why?
T-Lymphocytes
2
2010
316
0.340
Why?
NF-kappa B
3
2010
329
0.330
Why?
Arthritis, Rheumatoid
1
2011
116
0.330
Why?
Ticlopidine
1
2010
72
0.330
Why?
Gastric Juice
1
2010
6
0.320
Why?
Chemotaxis, Leukocyte
2
2007
13
0.320
Why?
Macrophage Inflammatory Proteins
2
2007
5
0.320
Why?
Endoscopy, Gastrointestinal
6
2012
74
0.320
Why?
Bacterial Proteins
3
2010
337
0.320
Why?
alpha 1-Antitrypsin
1
2010
14
0.320
Why?
Esophagitis
1
2009
9
0.310
Why?
Stomach Neoplasms
2
2010
194
0.310
Why?
Antigens, CD
1
2010
215
0.310
Why?
Neoplasm Staging
5
2021
766
0.300
Why?
Serologic Tests
1
2008
25
0.300
Why?
Breath Tests
1
2008
40
0.300
Why?
Platelet Aggregation Inhibitors
1
2010
211
0.300
Why?
Signal Transduction
7
2014
1699
0.290
Why?
Urea
1
2008
79
0.290
Why?
Anti-Ulcer Agents
2
2005
21
0.290
Why?
Sulfoxides
2
2005
21
0.290
Why?
Antibodies, Antinuclear
2
2007
14
0.290
Why?
Polymorphism, Single Nucleotide
1
2011
504
0.290
Why?
Benzimidazoles
2
2005
50
0.290
Why?
Chemokines, CC
2
2007
9
0.280
Why?
Atherosclerosis
1
2010
225
0.280
Why?
Gastric Mucosa
2
2007
44
0.280
Why?
Acrylamides
2
2024
8
0.280
Why?
HLA-DR2 Antigen
1
2007
1
0.280
Why?
Prospective Studies
9
2019
2424
0.280
Why?
Cell Proliferation
2
2014
1017
0.280
Why?
Amoxicillin
4
2014
20
0.270
Why?
Receptors, Chemokine
1
2007
13
0.270
Why?
Liver
7
2014
1154
0.270
Why?
Enzyme Activation
5
2010
269
0.270
Why?
Mutation
2
2024
1318
0.260
Why?
Liver Cirrhosis
6
2012
243
0.260
Why?
Mass Screening
1
2010
356
0.260
Why?
Pseudarthrosis
1
2006
1
0.260
Why?
Hepatitis C, Chronic
1
2007
86
0.260
Why?
Arthritis, Psoriatic
1
2006
9
0.260
Why?
Lupus Erythematosus, Systemic
2
2004
66
0.250
Why?
Polybrominated Biphenyls
1
2006
1
0.250
Why?
Flame Retardants
1
2006
2
0.250
Why?
Phenyl Ethers
1
2006
4
0.250
Why?
Epididymis
1
2006
8
0.250
Why?
Monocytes
4
2014
126
0.250
Why?
Spinal Fractures
1
2006
38
0.250
Why?
Proto-Oncogene Proteins c-bcl-2
4
2010
128
0.230
Why?
Peroxidase
1
2005
17
0.230
Why?
Viral Core Proteins
1
2005
6
0.230
Why?
DNA
3
2015
543
0.230
Why?
Gallstones
4
2009
13
0.230
Why?
Prenatal Exposure Delayed Effects
1
2007
193
0.220
Why?
Naphthoquinones
1
2004
10
0.220
Why?
Mitochondria, Liver
1
2005
69
0.220
Why?
Drug Hypersensitivity
1
2024
39
0.220
Why?
Aniline Compounds
1
2024
46
0.220
Why?
Hepacivirus
1
2005
105
0.210
Why?
Immunologic Factors
1
2005
117
0.210
Why?
Morpholines
1
2024
64
0.210
Why?
Alleles
1
2024
277
0.210
Why?
Antiviral Agents
3
2014
177
0.210
Why?
Cachexia
1
2003
28
0.210
Why?
Enzyme Inhibitors
1
2005
371
0.200
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2004
123
0.200
Why?
Triiodothyronine
1
2003
28
0.200
Why?
Young Adult
5
2019
4307
0.200
Why?
Sex Factors
4
2016
731
0.200
Why?
Reactive Oxygen Species
4
2007
421
0.200
Why?
Carrier Proteins
1
2005
316
0.200
Why?
Follow-Up Studies
8
2020
2282
0.200
Why?
Antibodies, Monoclonal
2
2020
475
0.190
Why?
Antibodies, Bispecific
1
2024
88
0.190
Why?
Pyrimidines
2
2024
198
0.190
Why?
Risk Assessment
5
2016
1339
0.190
Why?
CD4-Positive T-Lymphocytes
1
2004
163
0.190
Why?
Lipopolysaccharides
5
2008
204
0.190
Why?
2-Pyridinylmethylsulfinylbenzimidazoles
3
2014
18
0.180
Why?
Metronidazole
2
2012
28
0.180
Why?
Animals
12
2014
13332
0.180
Why?
Cells, Cultured
6
2015
1568
0.180
Why?
Clarithromycin
3
2014
38
0.180
Why?
Organometallic Compounds
2
2012
41
0.180
Why?
Treatment Outcome
12
2021
5456
0.180
Why?
Age Factors
4
2016
1125
0.180
Why?
Mice
8
2014
5877
0.180
Why?
Cross-Sectional Studies
3
2016
1665
0.180
Why?
Sigmoidoscopy
2
2014
10
0.180
Why?
Reproducibility of Results
2
2016
1214
0.170
Why?
Virus Replication
2
2014
150
0.170
Why?
Colorectal Neoplasms
1
2004
292
0.170
Why?
Drug Therapy, Combination
7
2013
399
0.170
Why?
Cohort Studies
2
2019
1541
0.160
Why?
Adenine
2
2013
30
0.160
Why?
Interferon-gamma
3
2012
172
0.160
Why?
Sulfones
1
2019
24
0.160
Why?
Chemoradiotherapy
1
2020
49
0.160
Why?
Salvage Therapy
1
2020
136
0.160
Why?
Recurrence
6
2012
680
0.160
Why?
Oncogene Proteins, Fusion
1
2019
60
0.150
Why?
Prognosis
6
2021
2093
0.150
Why?
Multivariate Analysis
4
2016
600
0.150
Why?
Genotype
3
2024
563
0.150
Why?
Sphincterotomy, Endoscopic
3
2009
15
0.150
Why?
Adolescent
5
2016
6681
0.140
Why?
Administration, Oral
1
2019
453
0.140
Why?
Platelet Aggregation
2
2010
77
0.140
Why?
Somatostatin
2
2008
28
0.140
Why?
Pancreatitis
2
2008
65
0.130
Why?
Reverse Transcriptase Polymerase Chain Reaction
6
2014
580
0.130
Why?
Carcinoma, Squamous Cell
1
2020
330
0.130
Why?
Mitogen-Activated Protein Kinases
2
2010
155
0.130
Why?
Sensitivity and Specificity
2
2010
871
0.130
Why?
Nadolol
2
2008
3
0.130
Why?
Risk Factors
5
2014
3922
0.130
Why?
Dose-Response Relationship, Drug
5
2007
1368
0.120
Why?
Caspase 9
2
2007
13
0.120
Why?
Alcohol Drinking
2
2009
236
0.120
Why?
Oligonucleotide Array Sequence Analysis
2
2015
411
0.120
Why?
Caspase 3
2
2007
91
0.120
Why?
Rats, Sprague-Dawley
4
2014
1534
0.120
Why?
Cell Line, Tumor
3
2010
1418
0.120
Why?
Animals, Newborn
2
2007
361
0.120
Why?
Severity of Illness Index
5
2012
1035
0.120
Why?
Injections, Intraperitoneal
2
2007
56
0.120
Why?
Membrane Potentials
2
2006
102
0.120
Why?
Sperm Count
2
2006
11
0.110
Why?
Sperm Motility
2
2006
12
0.110
Why?
Adenosine Diphosphate
2
2004
20
0.110
Why?
P-Selectin
2
2004
27
0.110
Why?
Guanine
3
2014
40
0.110
Why?
Caspases
2
2005
102
0.110
Why?
Leukocytes
2
2004
59
0.110
Why?
Toll-Like Receptor 9
1
2014
10
0.110
Why?
Intestinal Polyps
1
2014
7
0.110
Why?
Cyclooxygenase 2 Inhibitors
1
2014
22
0.110
Why?
Tumor Suppressor Protein p53
2
2007
224
0.110
Why?
PTEN Phosphohydrolase
1
2014
55
0.110
Why?
Thromboembolism
1
2014
49
0.100
Why?
Thymidine
1
2013
17
0.100
Why?
Aryl Hydrocarbon Hydroxylases
2
2011
76
0.100
Why?
Organophosphonates
1
2013
7
0.100
Why?
Mice, Inbred C57BL
4
2013
1872
0.100
Why?
Flow Cytometry
4
2014
397
0.100
Why?
Hysterectomy
1
2014
90
0.100
Why?
Immunocompetence
1
2013
19
0.100
Why?
Dobutamine
2
2003
20
0.100
Why?
Toll-Like Receptor 3
1
2013
9
0.100
Why?
Adrenergic beta-Agonists
2
2003
42
0.100
Why?
Chemokine CCL2
2
2003
65
0.100
Why?
Interferons
1
2013
37
0.100
Why?
Area Under Curve
2
2012
182
0.100
Why?
Warfarin
1
2014
82
0.100
Why?
Cholangiopancreatography, Endoscopic Retrograde
3
2009
89
0.100
Why?
Gene Frequency
2
2011
98
0.100
Why?
Rats
4
2014
3146
0.100
Why?
Secondary Prevention
2
2010
84
0.100
Why?
Cyclooxygenase 2
2
2014
50
0.100
Why?
Interleukin-6
2
2012
274
0.100
Why?
Protein Transport
2
2010
166
0.100
Why?
Pyrazoles
1
2014
113
0.100
Why?
ROC Curve
2
2012
250
0.100
Why?
Sulfonamides
1
2014
132
0.100
Why?
Cell Line
5
2012
1018
0.100
Why?
Ofloxacin
1
2012
6
0.100
Why?
Quality Control
1
2013
98
0.100
Why?
Observer Variation
1
2013
131
0.100
Why?
Cholecystectomy
1
2012
31
0.100
Why?
Hepatitis B
2
2010
16
0.100
Why?
TNF Receptor-Associated Factor 6
1
2012
6
0.100
Why?
Blood Platelets
2
2004
244
0.090
Why?
Cesarean Section
1
2014
183
0.090
Why?
Elasticity Imaging Techniques
1
2012
29
0.090
Why?
Pregnancy
3
2014
2658
0.090
Why?
Interleukins
1
2012
34
0.090
Why?
Gene Expression Regulation
4
2015
1000
0.090
Why?
Enzyme-Linked Immunosorbent Assay
2
2010
234
0.090
Why?
Mitochondria
2
2006
421
0.090
Why?
Chromatography, High Pressure Liquid
1
2013
335
0.090
Why?
Mice, Inbred BALB C
1
2012
307
0.090
Why?
Spleen
1
2012
169
0.090
Why?
Retrospective Studies
4
2021
6610
0.090
Why?
Tandem Mass Spectrometry
1
2013
249
0.090
Why?
Oligonucleotide Probes
1
2011
19
0.090
Why?
Tetracycline
1
2011
20
0.090
Why?
Immunohistochemistry
2
2013
975
0.090
Why?
Anticoagulants
1
2014
276
0.090
Why?
Polymorphism, Restriction Fragment Length
1
2011
66
0.090
Why?
Nucleic Acid Hybridization
1
2011
54
0.090
Why?
Feasibility Studies
1
2013
399
0.090
Why?
ZAP-70 Protein-Tyrosine Kinase
1
2010
3
0.090
Why?
Protein Kinase Inhibitors
2
2024
225
0.090
Why?
Jurkat Cells
1
2010
28
0.090
Why?
Platelet Function Tests
1
2010
22
0.090
Why?
Polymorphism, Genetic
2
2011
182
0.090
Why?
Drug Administration Schedule
5
2013
374
0.080
Why?
Organ Size
2
2012
229
0.080
Why?
Gene Expression Profiling
1
2015
1101
0.080
Why?
Drug Interactions
1
2010
201
0.080
Why?
Disease Progression
3
2014
866
0.080
Why?
bcl-X Protein
1
2010
54
0.080
Why?
Lymphoma, B-Cell
1
2010
61
0.080
Why?
Lymphocytes, Tumor-Infiltrating
1
2010
78
0.080
Why?
Areca
1
2009
1
0.080
Why?
Gallbladder Neoplasms
1
2009
7
0.080
Why?
Logistic Models
2
2009
925
0.080
Why?
Tumor Cells, Cultured
2
2014
445
0.080
Why?
Cell Differentiation
1
2012
670
0.080
Why?
Osteoclasts
1
2012
427
0.080
Why?
bcl-2-Associated X Protein
2
2007
58
0.080
Why?
B-Lymphocytes
1
2010
180
0.080
Why?
Endotoxins
1
2009
22
0.080
Why?
Bilirubin
2
2007
44
0.080
Why?
Catechols
1
2008
8
0.070
Why?
Capsules
1
2008
29
0.070
Why?
Albumins
1
2009
29
0.070
Why?
DNA, Viral
3
2014
138
0.070
Why?
Body Mass Index
2
2009
699
0.070
Why?
Peritonitis
1
2009
24
0.070
Why?
Intestinal Mucosa
2
2007
222
0.070
Why?
Nitric Oxide Synthase Type II
1
2008
62
0.070
Why?
Antibodies, Bacterial
1
2008
30
0.070
Why?
Chi-Square Distribution
1
2009
292
0.070
Why?
Carbon Isotopes
1
2008
70
0.070
Why?
Isosorbide Dinitrate
1
2008
1
0.070
Why?
B-Cell Activating Factor
1
2008
3
0.070
Why?
Prevalence
2
2009
1013
0.070
Why?
Digestive System Surgical Procedures
1
2008
32
0.070
Why?
Adenomyoma
1
2008
2
0.070
Why?
Jejunal Neoplasms
1
2008
4
0.070
Why?
Dietary Fats
1
2009
133
0.070
Why?
Immunoglobulin G
1
2008
195
0.070
Why?
Antibody Specificity
1
2007
36
0.070
Why?
p38 Mitogen-Activated Protein Kinases
2
2008
94
0.070
Why?
Ligands
2
2006
206
0.070
Why?
Vasodilator Agents
1
2008
93
0.070
Why?
Adrenergic beta-Antagonists
1
2008
111
0.070
Why?
Radiopharmaceuticals
1
2008
199
0.070
Why?
Phenotype
1
2010
794
0.070
Why?
Chemokine CCL20
1
2007
1
0.070
Why?
Receptors, CCR6
1
2007
3
0.070
Why?
Receptors, CXCR3
1
2007
4
0.070
Why?
Receptors, CCR5
1
2007
7
0.070
Why?
Survival Rate
3
2020
945
0.070
Why?
Gene Expression Regulation, Enzymologic
1
2008
181
0.070
Why?
Models, Biological
2
2008
731
0.070
Why?
Immunologic Memory
1
2007
32
0.070
Why?
DNA Primers
2
2004
204
0.070
Why?
Lymphoma, Large B-Cell, Diffuse
1
2008
105
0.070
Why?
T-Lymphocyte Subsets
1
2007
40
0.070
Why?
Th1 Cells
1
2007
52
0.070
Why?
Time Factors
2
2010
2970
0.060
Why?
Interleukin-8
2
2005
86
0.060
Why?
Inflammation Mediators
1
2007
115
0.060
Why?
Chemotaxis
2
2003
21
0.060
Why?
Spondylitis, Ankylosing
1
2006
10
0.060
Why?
Halogenated Diphenyl Ethers
1
2006
3
0.060
Why?
Pilot Projects
2
2005
712
0.060
Why?
Steroid 11-beta-Hydroxylase
1
2006
1
0.060
Why?
Hemostasis, Endoscopic
1
2006
4
0.060
Why?
RNA, Messenger
5
2014
1135
0.060
Why?
Ligation
4
2008
59
0.060
Why?
Macrophages
1
2008
360
0.060
Why?
Proto-Oncogene Proteins
2
2008
149
0.060
Why?
Gastroscopy
1
2005
21
0.060
Why?
Cytokines
1
2009
621
0.060
Why?
Case-Control Studies
3
2014
1193
0.060
Why?
Ketotifen
1
2005
2
0.060
Why?
Leukotriene Antagonists
1
2005
5
0.060
Why?
Histamine H1 Antagonists
1
2005
9
0.060
Why?
Caspase 8
1
2005
10
0.060
Why?
Genes, Bacterial
1
2005
51
0.060
Why?
Fas Ligand Protein
1
2005
17
0.060
Why?
Chromatin
1
2006
141
0.060
Why?
Diet
1
2009
600
0.060
Why?
Quinolines
1
2005
43
0.060
Why?
BH3 Interacting Domain Death Agonist Protein
1
2005
14
0.060
Why?
Chemokines
1
2005
78
0.060
Why?
Acetates
1
2005
51
0.060
Why?
Anti-Asthmatic Agents
1
2005
33
0.060
Why?
Hydrolysis
1
2005
69
0.060
Why?
Stevens-Johnson Syndrome
1
2024
4
0.060
Why?
HLA-B Antigens
1
2024
8
0.060
Why?
Kaplan-Meier Estimate
2
2021
482
0.060
Why?
Cyclin-Dependent Kinase Inhibitor p27
1
2004
17
0.060
Why?
Cytochromes c
1
2004
28
0.060
Why?
Anesthesia, Inhalation
1
2004
12
0.060
Why?
Antineoplastic Agents
2
2024
1214
0.060
Why?
Midazolam
1
2004
37
0.060
Why?
Chronic Disease
1
2007
585
0.060
Why?
Anesthetics, Intravenous
1
2004
22
0.060
Why?
Poly(ADP-ribose) Polymerases
1
2004
30
0.060
Why?
Methyl Ethers
1
2004
18
0.060
Why?
Cholesterol
1
2005
160
0.060
Why?
Gene Expression
1
2007
618
0.060
Why?
DNA Fragmentation
1
2004
53
0.050
Why?
Injections, Subcutaneous
1
2024
51
0.050
Why?
Patient Compliance
1
2005
229
0.050
Why?
Receptors, Interleukin-2
1
2004
6
0.050
Why?
Coculture Techniques
1
2004
142
0.050
Why?
Antibodies, Blocking
1
2004
5
0.050
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2004
6
0.050
Why?
Immunotoxins
1
2004
6
0.050
Why?
Administration, Intravenous
1
2024
73
0.050
Why?
Immunoglobulin Fc Fragments
1
2004
11
0.050
Why?
Tranexamic Acid
1
2004
15
0.050
Why?
Esophagoscopy
1
2004
27
0.050
Why?
Receptors, Tumor Necrosis Factor
1
2004
36
0.050
Why?
Leukocytes, Mononuclear
2
2015
122
0.050
Why?
Interleukin-2
1
2004
68
0.050
Why?
Body Weight
1
2006
526
0.050
Why?
Cystitis
1
2004
17
0.050
Why?
Protein Processing, Post-Translational
1
2005
151
0.050
Why?
Tumor Suppressor Proteins
1
2004
128
0.050
Why?
Protozoan Proteins
1
2004
32
0.050
Why?
Jaundice, Obstructive
1
2003
6
0.050
Why?
Pancreatic Pseudocyst
1
2003
8
0.050
Why?
Cell Cycle Proteins
1
2004
167
0.050
Why?
Lidocaine
1
2003
46
0.050
Why?
Polymerase Chain Reaction
1
2004
460
0.050
Why?
Recombinant Fusion Proteins
1
2004
173
0.050
Why?
Cell Division
1
2004
288
0.050
Why?
Anesthetics, Local
1
2003
77
0.050
Why?
Recombinant Proteins
1
2004
492
0.050
Why?
Hemorrhage
1
2004
222
0.050
Why?
Oocytes
1
2003
96
0.050
Why?
Acute Disease
3
2008
386
0.050
Why?
Hepatocytes
2
2013
190
0.050
Why?
Amphetamines
1
2002
26
0.050
Why?
Phencyclidine
1
2002
32
0.050
Why?
Indoles
1
2024
276
0.050
Why?
Excitatory Amino Acid Antagonists
1
2002
45
0.050
Why?
Parkinsonian Disorders
1
2001
12
0.050
Why?
Dinoprostone
2
2014
49
0.050
Why?
Proto-Oncogene Proteins c-fos
1
2001
60
0.050
Why?
Dopamine Uptake Inhibitors
1
2002
54
0.050
Why?
Proteins
1
2004
347
0.050
Why?
Proto-Oncogene Proteins c-jun
1
2001
76
0.040
Why?
Receptors, N-Methyl-D-Aspartate
1
2002
75
0.040
Why?
Asthma
1
2005
314
0.040
Why?
Proto-Oncogene Proteins c-akt
2
2014
170
0.040
Why?
Infusions, Intra-Arterial
2
2014
13
0.040
Why?
Mitomycin
2
2014
19
0.040
Why?
Molecular Targeted Therapy
1
2021
132
0.040
Why?
Hepatic Artery
2
2014
21
0.040
Why?
Fluorouracil
2
2014
57
0.040
Why?
Hepatitis B Surface Antigens
2
2013
6
0.040
Why?
Disease Management
1
2021
185
0.040
Why?
Transfection
2
2013
366
0.040
Why?
Lymphocytes
1
2020
146
0.040
Why?
Predictive Value of Tests
2
2012
939
0.040
Why?
Inflammation
1
2003
641
0.040
Why?
Neutrophils
1
2020
146
0.040
Why?
Neoplasm Metastasis
1
2019
236
0.040
Why?
Reference Values
2
2012
313
0.040
Why?
Cell Movement
3
2003
273
0.040
Why?
Calcium
3
2003
372
0.030
Why?
Incidence
2
2014
1070
0.030
Why?
Brain
2
2002
1311
0.030
Why?
Amino Acid Sequence
2
2010
566
0.030
Why?
Probability
2
2009
171
0.030
Why?
Smoke
1
2015
18
0.030
Why?
Fluorescent Antibody Technique
1
2014
109
0.030
Why?
Immunoenzyme Techniques
1
2014
135
0.030
Why?
Interferon-alpha
1
2014
52
0.030
Why?
Viral Load
1
2014
80
0.030
Why?
Drug Resistance, Viral
1
2013
8
0.030
Why?
Hepatitis B e Antigens
1
2013
4
0.030
Why?
Transcriptional Activation
1
2014
128
0.030
Why?
Appendectomy
1
2014
36
0.030
Why?
Depression, Chemical
2
2003
13
0.030
Why?
Early Detection of Cancer
1
2015
183
0.030
Why?
PPAR gamma
1
2014
72
0.030
Why?
Pelvis
1
2014
66
0.030
Why?
Abdomen
1
2014
73
0.030
Why?
Adenoviridae
1
2013
47
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2014
182
0.030
Why?
Neoplastic Stem Cells
1
2014
90
0.030
Why?
Promoter Regions, Genetic
2
2006
465
0.030
Why?
Proportional Hazards Models
2
2004
439
0.020
Why?
Immunophenotyping
1
2013
117
0.020
Why?
Genome, Viral
1
2013
80
0.020
Why?
Tomography, X-Ray Computed
2
2009
1148
0.020
Why?
Genetic Vectors
1
2013
128
0.020
Why?
Blotting, Western
1
2014
588
0.020
Why?
Dependovirus
1
2013
103
0.020
Why?
Elasticity
1
2012
19
0.020
Why?
Albuterol
2
2003
57
0.020
Why?
Platelet Count
1
2012
76
0.020
Why?
Ubiquitination
1
2012
57
0.020
Why?
Alanine Transaminase
1
2012
120
0.020
Why?
Liver Function Tests
1
2012
48
0.020
Why?
RNA, Small Interfering
1
2012
215
0.020
Why?
Dopamine
2
2003
169
0.020
Why?
Base Sequence
1
2012
627
0.020
Why?
Drug Resistance, Bacterial
1
2011
76
0.020
Why?
Cerebral Cortex
2
2002
191
0.020
Why?
Blotting, Southern
1
2010
42
0.020
Why?
Blotting, Northern
1
2010
108
0.020
Why?
Sequence Deletion
1
2010
72
0.020
Why?
Hyperamylasemia
1
2008
1
0.020
Why?
Fatty Alcohols
1
2008
2
0.020
Why?
Mice, Inbred ICR
1
2008
25
0.020
Why?
I-kappa B Proteins
1
2008
16
0.020
Why?
Metabolic Clearance Rate
1
2009
67
0.020
Why?
Radionuclide Imaging
1
2009
104
0.020
Why?
Extracellular Signal-Regulated MAP Kinases
1
2008
83
0.020
Why?
Statistics, Nonparametric
1
2009
196
0.020
Why?
Liver Regeneration
1
2008
47
0.020
Why?
Hyperplasia
1
2008
97
0.020
Why?
Infusions, Intravenous
1
2009
218
0.020
Why?
Bacterial Infections
1
2009
96
0.020
Why?
Phosphatidylinositol 3-Kinases
1
2008
149
0.020
Why?
Cell Nucleus
1
2008
188
0.020
Why?
Mucous Membrane
1
2007
31
0.020
Why?
Adaptor Proteins, Signal Transducing
1
2008
198
0.020
Why?
Duodenum
1
2007
34
0.020
Why?
Nitric Oxide
1
2009
234
0.020
Why?
Esophagus
1
2007
83
0.020
Why?
Flavones
1
2006
5
0.020
Why?
Dactinomycin
1
2006
23
0.020
Why?
Receptors, Aryl Hydrocarbon
1
2006
30
0.020
Why?
S100 Proteins
1
2006
33
0.020
Why?
RNA Processing, Post-Transcriptional
1
2006
23
0.020
Why?
DNA, Complementary
1
2006
129
0.010
Why?
Treatment Failure
1
2006
122
0.010
Why?
Emergencies
1
2006
80
0.010
Why?
Skin
1
2008
418
0.010
Why?
Chemokine CCL17
1
2005
1
0.010
Why?
Chemokine CCL22
1
2005
1
0.010
Why?
Peak Expiratory Flow Rate
1
2005
9
0.010
Why?
Sulfides
1
2005
29
0.010
Why?
Th2 Cells
1
2005
21
0.010
Why?
Cyclopropanes
1
2005
27
0.010
Why?
Acids
1
2005
10
0.010
Why?
Respiratory Function Tests
1
2005
89
0.010
Why?
Stress, Psychological
1
2007
273
0.010
Why?
Diagnosis, Differential
1
2008
1031
0.010
Why?
Drug Resistance
1
2005
68
0.010
Why?
RNA
1
2006
169
0.010
Why?
Hydrogen-Ion Concentration
1
2005
177
0.010
Why?
alpha-Fetoproteins
1
2004
12
0.010
Why?
Hemostasis, Surgical
1
2004
12
0.010
Why?
Leucovorin
1
2004
18
0.010
Why?
Hepatitis C Antibodies
1
2004
19
0.010
Why?
Transcription Factors
1
2008
564
0.010
Why?
Hepatectomy
1
2004
23
0.010
Why?
Endoscopes, Gastrointestinal
1
2004
3
0.010
Why?
Virulence Factors
1
2005
76
0.010
Why?
Omeprazole
1
2004
16
0.010
Why?
Dizziness
1
2004
13
0.010
Why?
Cardiolipins
1
2004
2
0.010
Why?
Hydronephrosis
1
2004
13
0.010
Why?
Pancreatitis, Alcoholic
1
2003
2
0.010
Why?
Exanthema
1
2004
32
0.010
Why?
Ribosomal Proteins
1
2004
24
0.010
Why?
Chemokine CCL4
1
2003
5
0.010
Why?
Chemokine CCL3
1
2003
12
0.010
Why?
Electrophoresis, Polyacrylamide Gel
1
2003
93
0.010
Why?
Double-Blind Method
1
2005
718
0.010
Why?
Autoantibodies
1
2004
120
0.010
Why?
Survival Analysis
1
2004
667
0.010
Why?
Dopamine Antagonists
1
2002
22
0.010
Why?
L-Lactate Dehydrogenase
1
2002
71
0.010
Why?
Binding, Competitive
1
2002
90
0.010
Why?
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
1
2001
5
0.010
Why?
Tyrosine 3-Monooxygenase
1
2001
10
0.010
Why?
Neostriatum
1
2001
9
0.010
Why?
Glycine
1
2002
75
0.010
Why?
Cell Death
1
2002
169
0.010
Why?
Cell Membrane
1
2002
231
0.010
Why?
Cerebellum
1
2001
120
0.010
Why?
Kinetics
1
2002
616
0.010
Why?
Postoperative Complications
1
2004
1071
0.010
Why?
Child
1
2005
7147
0.010
Why?
Hsu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_
Same Department Expand Description